Clindamycin News and Research

RSS

What medicine-exposed rats reveal about the next urban zoonotic threat

Researchers found that more than half of urban rats sampled from low-income communities in Salvador, Brazil, carried active pharmaceutical ingredients in their brain tissue. These pollutants were associated with altered zoonotic infection patterns, including lower Leptospira infection probability in rats carrying azithromycin and higher Capillaria infection probability in rats carrying citalopram.

22 May 2026

COCOON trial protocol halves skin toxicities in lung cancer treatment

A new research perspective was published in Volume 13 of Oncoscience on March 11, 2026, titled "Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC."

3 Apr 2026

How one antibiotic dose can reshape your gut microbiome for years

Long-term registry-linked analysis of nearly 15,000 adults shows that antibiotic use is associated with persistent changes in gut microbiome diversity and composition for up to 4–8 years. These effects vary by antibiotic class, with clindamycin, fluoroquinolones, and flucloxacillin showing the strongest and most sustained associations.

17 Mar 2026

Some antibiotics alter gut microbiome composition for up to eight years

Antibiotic treatments can affect the composition of the community of bacteria living in the gut, known as the gut microbiome, for a long time.

11 Mar 2026

Frozen in time: Ancient bacteria reveal evolution of drug resistance

Bacteria have evolved to adapt to all of Earth's most extreme conditions, from scorching heat to temperatures well below zero.

17 Feb 2026

Evolving epidemiology of invasive Group A Streptococcus in critical care

Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS infections can quickly escalate into life-threatening conditions such as necrotizing fasciitis, septic shock, and pneumonia.

6 Nov 2025

Vaginal microbiome fights back against stubborn BV infections

Vaginal microbiome-drug interactions affect antibiotic treatment for bacterial vaginosis, emphasizing the need for personalized approaches to enhance efficacy.

3 Jul 2025

When old diseases find new ways in: Europe’s latest diphtheria outbreak explained

A large multicountry outbreak of toxigenic Corynebacterium diphtheriae occurred among migrants entering Europe in 2022, driven primarily by cutaneous infections and involving multiple genetic lineages. Despite the unprecedented surge, transmission to resident populations was limited, but rising antimicrobial resistance and delayed treatment highlight ongoing public health risks.

10 Jun 2025

New PCR test offers hope for better treatment of bacterial vaginosis

Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime.

28 Mar 2025

Study highlights the need for more diversity in vaginal microbiome research

This study emphasizes the need for global equity in vaginal microbiome research, addressing health disparities and improving female health strategies worldwide.

14 Feb 2025

Discovery of antibiotic lolamicin that targets deadly bacteria without harming gut microbiome

Researchers discovered lolamicin, a selective Gram-negative antibiotic, effective against multidrug-resistant pathogens while sparing the gut microbiome.

4 Jun 2024

New antibiotic lolamicin shows promise in fighting drug-resistant infections

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut.

29 May 2024

Researchers highlight critical need for more effective treatments for women with bacterial vaginosis

Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk.

2 May 2024

Novel synthetic antibiotic effective against drug-resistant bacteria

A new antibiotic created by Harvard researchers overcomes antimicrobial resistance mechanisms that have rendered many modern drugs ineffective and are driving a global public health crisis.

15 Feb 2024

New study reveals cefoxitin as effective first-line treatment for intraamniotic infections

The effectiveness of Cefoxitin in the treatment of Endometritis and Intraamniotic Infections (IAI).

5 Feb 2024

Alarming rise in antibiotic-resistant urogenital infections in Greece, study shows escalating resistance trends

The trends in antimicrobial resistance in Greece.

1 Dec 2023

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

The use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria.

27 Sep 2023

Dangerous antibiotic-resistant bacteria found in China's ready-to-eat foods

The study reveals high levels of antibiotic-resistant Staphylococcus aureus (MRSA) in ready-to-eat foods across 25 provinces in China, posing a serious public health risk. The findings emphasize the need for stronger food safety measures, as the MRSA strains identified were resistant to multiple antibiotics and exhibited various virulence factors.

10 Sep 2023

Pharmacist-led intervention can help suppress multi-drug resistant pathogens

The battle to stop the increase of superbugs in hospitals has been an ongoing struggle for healthcare professionals.

13 Jul 2023

Inappropriate antibiotic use in low and middle-income countries disrupts infant gut health, fuels antimicrobial resistance

Overuse of antibiotics contributes to the problem of drug-resistant bacteria. Developing countries and young children are particularly affected. Review examines how antibiotics affect gut bacteria and drug resistance in infants in low- and middle-income countries.

2 Jul 2023